ReviewVeterinary and animal science2025
Feline lymphoma associated with feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) infections in Brazil- Systematic review.
Review in Veterinary and animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphoma is the most common neoplasia in cats and is frequently linked with concurrent retroviral infections. Despite preventive strategies, feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) remain endemic in many parts of the world, with FeLV significantly shortening the lifespan of infected cats. In Brazil and other low-income countries, the incidence of FeLV and FIV remains high. However, the distribution of these retroviruses across South America is still unclear, and their correlation with the anatomical and clinical features of feline lymphoma remains poorly understood. Gaining a deeper understanding of these associations could lead to more effective disease control strategies and better-defined chemotherapy protocols. In this study, we examined the geographical distribution and clinical presentations of feline lymphoma in retrovirus-positive cats in Brazil. A modified bias risk analysis assessed the quality of published studies, and a map was created to highlight areas in need of further research. Initial screening of 703 studies identified 29 relevant ones, encompassing 607 cats with feline lymphoma. After bias analysis, 273 cases were included in this review: 190 were FeLV-positive and FIV-negative, 98 were FeLV-negative and FIV-negative, and 15 were FeLV-negative and FIV-positive. Cases were reported from six Brazilian states and the Federal District of Brazil (2000-2023). The anatomical location of lymphoma varied depending on the cats' viral status, with notable differences in intestinal and mediastinal manifestations. FeLV-negative cats showed an 11.1-fold increased risk (95 % CI=6.0-20.0) for intestinal lymphoma, while FeLV-positive cases had a 7.5-fold increased risk (95 % CI=3.7-15.6) for mediastinal lymphoma. Due to the scarcity of FIV-related cases, analyzing associations was not feasible. Given the apparent association between FeLV-positive status and lymphoma location, further research into this neoplasm is strongly encouraged. We also recommend widespread retrovirus testing and expanded FeLV vaccination efforts in Brazil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.